<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PRGO
Perrigo
$
()


  • Perrigo appoints Charles Atkinson as General Counsel

    9/4/2024 - 08:03am
  • Perrigo names David Ball as Chief Brand and Digital Officer

    8/19/2024 - 08:32am
  • What You Missed On Wall Street On Friday

    8/2/2024 - 16:24pm
  • What You Missed On Wall Street This Morning

    8/2/2024 - 11:55am
  • Fly Intel: Pre-market Movers

    8/2/2024 - 08:55am
  • Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.25

    8/2/2024 - 06:42am
  • Perrigo reports Q2 adjusted EPS 53c, consensus 46c

    8/2/2024 - 06:38am
  • Perrigo price target lowered by $1 at Piper Sandler, here's why

    7/11/2024 - 06:43am
  • Perrigo completes divestment of HRA Pharma Rare Diseases business to Esteve

    7/10/2024 - 08:04am
  • Perrigo price target lowered by $3 at Piper Sandler, here's why

    6/13/2024 - 06:24am
  • Perrigo earnings selloff a buying opportunity, says JPMorgan

    5/7/2024 - 20:48pm
  • Perrigo backs FY24 adjusted EPS view $2.50-$2.65, consensus $2.35

    5/7/2024 - 06:50am
  • Perrigo reports Q1 adjusted EPS 29c, consensus 23c

    5/7/2024 - 06:48am
  • Perrigo to sell HRA Pharma Rare Diseases business for EUR 275M

    4/25/2024 - 06:33am
  • Perrigo price target raised by $4 at Piper Sandler, here's why

    4/8/2024 - 06:42am
dynamic_feed Breaking News